**Core Concept**
Human papillomavirus (HPV) infection is a major risk factor for cervical cancer. Vaccination against HPV is an effective preventive measure, particularly for young women before they become sexually active.

**Why the Correct Answer is Right**
Gardasil is a vaccine developed to protect against HPV types 6, 11, 16, and 18. It is a recombinant vaccine that uses virus-like particles to stimulate an immune response against these high-risk HPV types. By vaccinating against HPV types 16 and 18, Gardasil reduces the risk of developing cervical cancer, as well as other anogenital cancers and genital warts caused by these types. This vaccine is particularly recommended for young women aged 9-26 years, ideally before they become sexually active.

**Why Each Wrong Option is Incorrect**
**Option A:** There is no vaccine called "Rabivac" that protects against HPV or cervical cancer. Rabies vaccine is a different type of vaccine that is used to protect against rabies.
**Option B:** "Biovac" is not a recognized vaccine for HPV or cervical cancer prevention. Biovac is not a widely known vaccine name in medical literature.
**Option D:** "Tvac" is not a recognized vaccine for HPV or cervical cancer prevention. TVAC is not a valid abbreviation for a vaccine name in medical literature.

**Clinical Pearl / High-Yield Fact**
The HPV vaccine is most effective when administered before exposure to HPV, ideally in the early teenage years. This is why it is recommended to vaccinate young girls before they become sexually active.

✓ Correct Answer: A. Gardasil